Coibamide A, a natural lariat depsipeptide, inhibits VEGFA/VEGFR2 expression and suppresses tumor growth in glioblastoma xenografts
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Coibamide A, a natural lariat depsipeptide, inhibits VEGFA/VEGFR2 expression and suppresses tumor growth in glioblastoma xenografts
Authors
Keywords
Coibamide A, Apratoxin A, Cyclic depsipeptide, Antiangiogenic, Autophagy, Glioblastoma
Journal
INVESTIGATIONAL NEW DRUGS
Volume 34, Issue 1, Pages 24-40
Publisher
Springer Nature
Online
2015-11-12
DOI
10.1007/s10637-015-0303-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Apoptolidins A and C activate AMPK in metabolically sensitive cell types and are mechanistically distinct from oligomycin A
- (2015) Jeffrey D. Serrill et al. BIOCHEMICAL PHARMACOLOGY
- Efficient Synthesis and Stereochemical Revision of Coibamide A
- (2015) Guiyang Yao et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Live to die another way: modes of programmed cell death and the signals emanating from dying cells
- (2015) Yaron Fuchs et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Antibody–drug conjugates—A new wave of cancer drugs
- (2014) Hervé Bouchard et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Improved Total Synthesis and Biological Evaluation of Potent Apratoxin S4 Based Anticancer Agents with Differential Stability and Further Enhanced Activity
- (2014) Qi-Yin Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Marine-Sourced Anti-Cancer and Cancer Pain Control Agents in Clinical and Late Preclinical Development
- (2014) David Newman et al. Marine Drugs
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
- (2014) Olivier L. Chinot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms of Glioma Formation: Iterative Perivascular Glioma Growth and Invasion Leads to Tumor Progression, VEGF-Independent Vascularization, and Resistance to Antiangiogenic Therapy
- (2014) Gregory J. Baker et al. NEOPLASIA
- Natural products: A continuing source of novel drug leads
- (2013) Gordon M. Cragg et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Form and Function in Cyclic Peptide Natural Products: A Pharmacokinetic Perspective
- (2013) Andrew T. Bockus et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- The role of Gliadel wafers in the treatment of high-grade gliomas
- (2013) Amade Bregy et al. Expert Review of Anticancer Therapy
- Apratoxin H and Apratoxin A Sulfoxide from the Red Sea Cyanobacterium Moorea producens
- (2013) Christopher C. Thornburg et al. JOURNAL OF NATURAL PRODUCTS
- Mechanisms of Glioma-Associated Neovascularization
- (2012) Matthew E. Hardee et al. AMERICAN JOURNAL OF PATHOLOGY
- Guidelines for the use and interpretation of assays for monitoring autophagy
- (2012) Daniel J. Klionsky et al. Autophagy
- A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics
- (2012) Stephanie D. Steichen et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
- (2012) David J. Newman et al. JOURNAL OF NATURAL PRODUCTS
- Identifying mechanism-of-action targets for drugs and probes
- (2012) E. Gregori-Puigjane et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Secretory Protein Profiling Reveals TNF-α Inactivation by Selective and Promiscuous Sec61 Modulators
- (2011) Sarah V. Maifeld et al. CHEMISTRY & BIOLOGY
- How were new medicines discovered?
- (2011) David C. Swinney et al. NATURE REVIEWS DRUG DISCOVERY
- Systematic Chemical Mutagenesis Identifies a Potent Novel Apratoxin A/E Hybrid with Improved in Vivo Antitumor Activity
- (2011) Qi-Yin Chen et al. ACS Medicinal Chemistry Letters
- Screening and Identification of Small Molecule Compounds Perturbing Mitosis Using Time-Dependent Cellular Response Profiles
- (2010) Ning Ke et al. ANALYTICAL CHEMISTRY
- Evolved Diversification of a Modular Natural Product Pathway: Apratoxins F and G, Two Cytotoxic Cyclic Depsipeptides from a Palmyra Collection of Lyngbya bouillonii
- (2010) Kevin Tidgewell et al. CHEMBIOCHEM
- The odyssey of marine pharmaceuticals: a current pipeline perspective
- (2010) Alejandro M.S. Mayer et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Kinetic Cell-Based Morphological Screening: Prediction of Mechanism of Compound Action and Off-Target Effects
- (2009) Yama A. Abassi et al. CHEMISTRY & BIOLOGY
- Cyclodepsipeptide toxin promotes the degradation of Hsp90 client proteins through chaperone-mediated autophagy
- (2009) Shensi Shen et al. JOURNAL OF CELL BIOLOGY
- Apratoxin A Reversibly Inhibits the Secretory Pathway by Preventing Cotranslational Translocation
- (2009) Y. Liu et al. MOLECULAR PHARMACOLOGY
- Coibamide A, a Potent Antiproliferative Cyclic Depsipeptide from the Panamanian Marine CyanobacteriumLeptolyngbyasp.
- (2008) Rebecca A. Medina et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Drug development from marine natural products
- (2008) Tadeusz F. Molinski et al. NATURE REVIEWS DRUG DISCOVERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started